Gelesis Holdings ROA 2021-2022 | GLS
Current and historical return on assets (ROA) values for Gelesis Holdings (GLS) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Gelesis Holdings ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2022-09-30 |
$0.14B |
$0.13B |
98.42% |
| 2022-06-30 |
$0.10B |
$0.14B |
55.94% |
| 2022-03-31 |
$0.01B |
$0.15B |
2.81% |
| 2021-12-31 |
$-0.00B |
$0.15B |
-0.82% |
| 2021-06-30 |
$-0.16B |
$0.28B |
-76.53% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.012B |
$0.011B |
|
Gelesis is a consumer-centered biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Gelesis, formerly known as Capstar Special Purpose Acquisition Corp., is based in BOSTON.
|
